TMS Co.,Ltd. 4891Short Interest
No institution currently reports a short position of 0.5% or more in TMS Co.,Ltd. (4891). The last disclosure was on 2026-11-16 (Barclays Capital Securities Ltd, 0.41%).
Estimated short interest
0.00%
±0.00%
Estimated position (shares)
0
As of 2026-11-18
Holders (0.5% or more)
0 firms
623 reports
Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It also excludes 9 institutions that fell below 0.5%. How estimates are calculated
Disclosure History Summary
| First disclosure | 2023-01-26 |
|---|---|
| Latest disclosure | 2026-11-16 (Barclays Capital Securities Ltd, 0.41%) |
| Reporting institutions | 13 firms (623 reports) |
| Peak estimated short interest | 13.76% (2025-02-21, 5 holders) |
Short Interest Trend Last 5 years, by institution, % of shares outstanding
Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 5 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.
- Jefferies International Limited
- Morgan Stanley MUFG Securities Co., Ltd.
- UBS AG
- Mizuho Securities Co., Ltd.
- JPM Securities Japan Co Ltd.
- Others
0.00%
Estimated short interest, 2026-11-18
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2023-10-31 | BNP Paribas Arbitrage SNC | Position 180,100 shares | Ratio 0.49% | ▼0.09% | Below 0.5% |
| 2023-11-06 | GOLDMAN SACHS INTERNATIONAL | Position 181,800 shares | Ratio 0.49% | ▼0.09% | Below 0.5% |
| 2025-03-03 | BNP Paribas Financial Markets SNC | Position 200,800 shares | Ratio 0.49% | ▼0.01% | Below 0.5% |
| 2026-10-19 | Nomura International plc | Position 224,200 shares | Ratio 0.46% | ▼0.21% | Below 0.5% |
| 2025-06-09 | JPM Securities Japan Co Ltd. | Position 205,600 shares | Ratio 0.45% | ▼0.12% | Below 0.5% |
| 2025-03-25 | UBS AG | Position 179,500 shares | Ratio 0.44% | ▼0.12% | Below 0.5% |
| 2023-06-09 | PDT Partners, LLC | Position 158,200 shares | Ratio 0.43% | ▼0.21% | Below 0.5% |
| 2026-11-16 | Barclays Capital Securities Ltd | Position 203,365 shares | Ratio 0.41% | ▼0.12% | Below 0.5% |
| 2024-07-11 | MERRILL LYNCH INTERNATIONAL | Position 138,800 shares | Ratio 0.34% | ▼0.17% | Below 0.5% |
| 2025-09-04 | Morgan Stanley MUFG Securities Co., Ltd. | Position 0 shares | Ratio 0.00% | ▼2.59% | Closed |
| 2025-05-09 | XTX Markets Pte Ltd | Position 0 shares | Ratio 0.00% | ▼0.87% | Closed |
| 2025-09-04 | Jefferies International Limited | Position 0 shares | Ratio 0.00% | ▼5.54% | Closed |
| 2026-09-14 | Mizuho Securities Co., Ltd. | Position 0 shares | Ratio 0.00% | ▼1.42% | Closed |
Disclosure History 623 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2026-11-16 | Barclays Capital Securities Ltd | Position 203,365 shares | Ratio 0.41% | ▼0.12% | Below 0.5% |
| 2026-11-13 | Barclays Capital Securities Ltd | Position 258,265 shares | Ratio 0.53% | ▼0.10% | — |
| 2026-11-05 | Barclays Capital Securities Ltd | Position 305,565 shares | Ratio 0.63% | ▲0.10% | — |
| 2026-11-02 | Barclays Capital Securities Ltd | Position 258,865 shares | Ratio 0.53% | ▲0.13% | — |
| 2026-10-19 | Nomura International plc | Position 224,200 shares | Ratio 0.46% | ▼0.21% | Below 0.5% |
| 2026-10-15 | Nomura International plc | Position 325,400 shares | Ratio 0.67% | ▲0.09% | — |
| 2026-10-14 | Nomura International plc | Position 283,300 shares | Ratio 0.58% | ▼0.19% | — |
| 2026-10-13 | Nomura International plc | Position 373,400 shares | Ratio 0.77% | ▲0.16% | — |
| 2026-10-08 | Nomura International plc | Position 296,200 shares | Ratio 0.61% | ▲0.11% | — |
| 2026-10-07 | Nomura International plc | Position 245,000 shares | Ratio 0.50% | ▲0.03% | — |
| 2026-09-14 | Mizuho Securities Co., Ltd. | Position 0 shares | Ratio 0.00% | ▼1.42% | Closed |
| 2026-09-09 | Barclays Capital Securities Ltd | Position 149,165 shares | Ratio 0.30% | ▼0.24% | Below 0.5% |
| 2026-09-08 | Barclays Capital Securities Ltd | Position 259,165 shares | Ratio 0.54% | ▼0.15% | — |
| 2026-09-07 | Barclays Capital Securities Ltd | Position 329,365 shares | Ratio 0.69% | ▼0.06% | — |
| 2026-08-24 | Barclays Capital Securities Ltd | Position 359,965 shares | Ratio 0.75% | ▼0.06% | — |
| 2026-08-21 | Barclays Capital Securities Ltd | Position 387,565 shares | Ratio 0.81% | ▲0.03% | — |
| 2026-08-20 | Barclays Capital Securities Ltd | Position 374,065 shares | Ratio 0.78% | ▼0.02% | — |
| 2026-08-19 | Barclays Capital Securities Ltd | Position 383,065 shares | Ratio 0.80% | ▲0.05% | — |
| 2026-08-18 | Barclays Capital Securities Ltd | Position 349,265 shares | Ratio 0.75% | ▼0.12% | — |
| 2026-08-18 | Mizuho Securities Co., Ltd. | Position 650,000 shares | Ratio 1.42% | ▲0.09% | — |
| 2026-08-17 | Mizuho Securities Co., Ltd. | Position 609,800 shares | Ratio 1.33% | ▲0.90% | — |
| 2026-08-10 | Barclays Capital Securities Ltd | Position 403,500 shares | Ratio 0.87% | ▼0.06% | — |
| 2026-08-06 | Mizuho Securities Co., Ltd. | Position 0 shares | Ratio 0.00% | ▼0.90% | Closed |
| 2026-08-05 | Barclays Capital Securities Ltd | Position 433,600 shares | Ratio 0.93% | ▲0.06% | — |
| 2026-08-04 | Barclays Capital Securities Ltd | Position 403,200 shares | Ratio 0.87% | ▼0.10% | — |
| 2026-07-29 | Barclays Capital Securities Ltd | Position 445,400 shares | Ratio 0.97% | ▼0.11% | — |
| 2026-07-27 | Barclays Capital Securities Ltd | Position 495,900 shares | Ratio 1.08% | ▼0.05% | — |
| 2026-07-24 | Barclays Capital Securities Ltd | Position 516,900 shares | Ratio 1.13% | ▲0.13% | — |
| 2026-07-17 | Barclays Capital Securities Ltd | Position 460,100 shares | Ratio 1.00% | ▼0.13% | — |
| 2026-07-16 | Mizuho Securities Co., Ltd. | Position 412,600 shares | Ratio 0.90% | ▲0.06% | — |
Shorted Stocks in the Same Industry Pharmaceutical
| Stock | Estimated ratio | Short sellers |
|---|---|---|
| GNI Group Ltd.2160 | 11.16% | 7 firms |
| Oncolys BioPharma Inc.4588 | 10.35% | 7 firms |
| HEALIOS K.K.4593 | 10.20% | 5 firms |
| SymBio Pharmaceuticals Limited4582 | 9.46% | 7 firms |
| Nxera Pharma Co.,Ltd.4565 | 7.35% | 5 firms |
Related Stocks Same TSE 33 sector
| Stock | Market | TSE 33 Sector | TOPIX-17 Sector | Index |
|---|---|---|---|---|
| ASKA Pharmaceutical Holdings Co.,Ltd.4886 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 2 |
| SAWAI GROUP HOLDINGS Co.,Ltd.4887 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Mid400 |
| STELLA PHARMA CORPORATION4888 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Renascience Inc.4889 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Tsubota Laboratory Incorporated4890 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Cyfuse Biomedical K.K.4892 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Noile-Immune Biotech Inc.4893 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Cuorips Inc.4894 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| K Pharma,Inc.4896 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Innovacell Inc.504A | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical |